Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: Single centre experience from a large tertiary care teaching hospital in Southern India

Seminars in Arthritis and Rheumatism

Volumn 47, Issue 5, 2018, Pages 718-726

  Goel, Ruchika ^a   Danda, Debashish ^a   Joseph, George ^a   Ravindran, Raheesh ^a,c   Kumar, Sathish ^a   Jayaseelan, Visali ^a   Jayaseelan, Lakshmanan ^a   Bacon, Paul ^b  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c Hiranandani Hospital   (India)

Author keywords

India; ITAS A; Outcome; Predictors; TADS; Takayasu arteritis

Indexed keywords

AZATHIOPRINE; METHOTREXATE; MYCOPHENOLIC ACID; PREDNISOLONE; TOCILIZUMAB; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANGIOGRAPHY; AORTIC ARCH SYNDROME; ARTICLE; CONTROLLED STUDY; CYTOPENIA; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; IMAGE ANALYSIS; IMMUNOSUPPRESSIVE TREATMENT; INDIA; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURVIVAL TIME; TEACHING HOSPITAL; TERTIARY CARE CENTER; TREATMENT OUTCOME; TREATMENT RESPONSE; ADOLESCENT; COMBINATION DRUG THERAPY; DISEASE EXACERBATION; REMISSION; TERTIARY HEALTH CARE; YOUNG ADULT;

ADOLESCENT; ADULT; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDIA; MALE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TAKAYASU ARTERITIS; TERTIARY HEALTHCARE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85032744149     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2017.09.014     Document Type: Article

References (23)

1. Numano, F., Kakuta, T., Takayasu arteritis—five doctors in the history of Takayasu arteritis. Int J Cardiol 54:Suppl. (1996), S1–S10.
2. Numano, F., The story of Takayasu arteritis. Rheumatol Oxf Engl 41 (2002), 103–106.
3. Kerr, G.S., Hallahan, C.W., Giordano, J., Leavitt, R.Y., Fauci, A.S., Rottem, M., et al. Takayasu arteritis. Ann Intern Med 120 (1994), 919–929.
4. Valsakumar, A.K., Valappil, U.C., Jorapur, V., Garg, N., Nityanand, S., Sinha, N., Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis. J Rheumatol 30 (2003), 1793–1798.
5. Yang, L., Zhang, H., Jiang, X., Zou, Y., Qin, F., Song, L., et al. Clinical manifestations and longterm outcome for patients with Takayasu arteritis in China. J Rheumatol 41 (2014), 2439–2446.
6. Ohigashi, H., Haraguchi, G., Konishi, M., Tezuka, D., Kamiishi, T., Ishihara, T., et al. Improved prognosis of Takayasu arteritis over the past decade. Circ J 76 (2012), 1004–1011.
7. Arnaud, L., Haroche, J., Limal, N., Toledano, D., Gambotti, L., Costedoat Chalumeau, N., et al. Takayasu arteritis in France: a single-center retrospective study of 82 cases comparing white, North African, and black patients. Medicine (Baltimore) 89 (2010), 1–17.
8. Watanabe, Y., Miyata, T., Tanemoto, K., Current clinical features of new patients with Takayasu arteritis observed from a cross-country research in Japan: age and sex specificity. Circulation, 114, 2015, 012547.
9. Schmidt, J., Kermani, T.A., Bacani, A.K., Crowson, C.S., Cooper, L.T., Matteson, E.L., et al. Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients. Mayo Clin Proc 88 (2013), 822–830.
10. Arend, W.P., Michel, B.A., Bloch, D.A., Hunder, G.G., Calabrese, L.H., Edworthy, S.M., et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33 (1990), 1129–1134.
11. Ishikawa, K., Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu's arteriopathy. J Am Coll Cardiol 12 (1988), 964–972.
12. Sharma, B.K., Jain, S., Suri, S., Numano, F., Diagnostic criteria for Takayasu arteritis. Int J Cardiol 54:Suppl (1996), S141–S147.
13. Sivakumar, M.R., Misra, R.N., Bacon, P.A., Op14. the Indian perspective of Takayasu arteritis and development of a disease extent index (dei.tak) to assess Takayasu arteritis. Rheumatology 44:Suppl. 3 (2005), iii6–iii7.
14. Hata, A., Noda, M., Moriwaki, R., Numano, F., Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 54:Suppl. (1996), S155–S163.
15. Goel, R., Kumar, T.S., Danda, D., Joseph, G., Jeyaseelan, V., Surin, A.K., et al. Childhood-onset Takayasu arteritis—experience from a tertiary care center in South India. J Rheumatol 41 (2014), 1183–1189.
16. Misra, R., Danda, D., Rajappa, S.M., Ghosh, A., Gupta, R., Mahendranath, K.M., et al. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatol Oxf Engl 52 (2013), 1795–1801.
17. Maksimowicz-McKinnon, K., Clark, T.M., Hoffman, G.S., Limitations of therapy and a guarded prognosis in an american cohort of takayasu arteritis patients. Arthritis Rheum 56 (2007), 1000–1009.
18. Hoffman, G.S., Leavitt, R.Y., Kerr, G.S., Rottem, M., Sneller, M.C., Fauci, A.S., Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum 37 (1994), 578–582.
19. Vanoli, M., Daina, E., Salvarani, C., Sabbadini, M.G., Rossi, C., Bacchiani, G., et al. Takayasu's arteritis: a study of 104 Italian patients. Arthritis Rheum 53 (2005), 100–107.
20. Brunner, J., Feldman, B.M., Tyrrell, P.N., Kuemmerle-Deschner, J.B., Zimmerhackl, L.B., Gassner, I., et al. Takayasu arteritis in children and adolescents. Rheumatol Oxf Engl 49 (2010), 1806–1814.
21. Ishikawa, K., Maetani, S., Long-term outcome for 120 Japanese patients with Takayasu's disease. Clinical and statistical analyses of related prognostic factors. Circulation 90 (1994), 1855–1860.
22. Goel, R., Danda, D., Mathew, J., Edwin, N., Mycophenolate mofetil in Takayasu's arteritis. Clin Rheumatol 29 (2010), 329–332.
23. Li, J., Yang, Y., Zhao, J., Li, M., Tian, X., Zeng, X., The efficacy of Mycophenolate mofetil for the treatment of Chinese Takayasu's arteritis. Sci Rep, 6, 2016, srep38687.